|Bid||98.70 x 200|
|Ask||100.65 x 300|
|Day's Range||98.40 - 104.49|
|52 Week Range||98.40 - 157.02|
|PE Ratio (TTM)||46.93|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Analysts at Morgan Stanley upgraded Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Thursday despite the stock's 17-percent loss year to date and two management shake-ups in the past six months alone. Morgan ...
Shares of Alexion Pharmaceuticals (ALXN) have been hammered the past two days after its new CEO cleaned house. But has it fallen too far? Investors, it seems, worry that the decision to replace much of ...
IN THE NEWS BENZINGA Bank investors hoping financial deregulation will open the door for a new golden era of banking in the near future will likely have to be patient and keep expectations in check: Link ...